Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 1288097)

Published in Adv Exp Med Biol on January 01, 1992

Authors

P Vaupel1, K H Schlenger, M Hoeckel, P Okunieff

Author Affiliations

1: Institute of Physiology and Pathophysiology, University of Mainz, Germany.

Articles by these authors

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res (1989) 12.85

Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res (1991) 4.12

Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med (1995) 3.43

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol (2001) 2.15

Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09

Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol (2001) 1.76

Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res (1989) 1.60

Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys (1995) 1.58

Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg (1999) 1.46

Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int J Radiat Oncol Biol Phys (1990) 1.26

Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. Radiat Res (1989) 1.23

Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys (1993) 1.23

Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys (2001) 1.19

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16

Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol (1993) 1.13

Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv Exp Med Biol (1998) 1.07

Predictive power of the tumor oxygenation status. Adv Exp Med Biol (1999) 1.02

Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors. Cancer Res (1990) 1.01

A new miniature x-ray device for interstitial radiosurgery: dosimetry. Med Phys (1996) 0.99

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. J Clin Oncol (2003) 0.99

Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int J Cancer (1989) 0.98

Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Cancer Res (2001) 0.97

Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate. Science (1997) 0.96

Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol (1995) 0.96

Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother Oncol (1991) 0.95

Blood flow, tissue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth. Adv Exp Med Biol (1989) 0.95

Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth. Nat Med (1996) 0.95

Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol (1992) 0.94

Extremity preservation by combined modality treatment of sarcomas of the hand and wrist. Int J Radiat Oncol Biol Phys (1986) 0.94

Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives. Cancer Res (1997) 0.93

Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis (2001) 0.92

Vascularization, blood flow, oxygenation, tissue pH, and bioenergetic status of human breast cancer. Adv Exp Med Biol (1997) 0.92

Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed (1994) 0.90

Is there a critical tissue oxygen tension for bioenergetic status and cellular pH regulation in solid tumors? Experientia (1996) 0.90

Oxygenation of human tumors: the Mainz experience. Strahlenther Onkol (1998) 0.88

Physiological properties of malignant tumours. NMR Biomed (1993) 0.87

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clin Proc (1997) 0.87

Blood flow and tissue oxygenation of human tumors: an update. Adv Exp Med Biol (1992) 0.86

Modulation of tumor oxygenation. Int J Radiat Oncol Biol Phys (1998) 0.86

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer. Ann Surg Oncol (1998) 0.85

An approach to dose measurement for total body irradiation. Int J Radiat Oncol Biol Phys (1996) 0.84

Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. Radiology (1995) 0.84

Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol (1990) 0.83

Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy. Am J Clin Oncol (2001) 0.83

Effect of intraperitoneal versus intravenous glucose administration on laser Doppler flow in murine FSaII tumors and normal skin. Cancer Res (1989) 0.82

Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement. J Natl Cancer Inst (1994) 0.82

A new biodosimetric method: branched DNA-based quantitative detection of B1 DNA in mouse plasma. Br J Radiol (2010) 0.82

Radioprotection of hematopoietic tissue by fibroblast growth factors in fractionated radiation experiments. Acta Oncol (1997) 0.81

Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas. J Natl Cancer Inst (1987) 0.81

Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva. Eur J Gynaecol Oncol (2006) 0.80

13C- and 31P-NMR studies of human colon cancer in-vitro and in-vivo. Surg Oncol (1993) 0.80

Effects of hypercapnia on brain pHi and phosphate metabolite regulation by 31P-NMR. J Appl Physiol (1985) (1989) 0.79

In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia. Int J Hyperthermia (1990) 0.79

The role of autocrine growth factors in radiation damage to the epiphyseal growth plate. Radiat Res (2001) 0.79

Acidic fibroblast growth factor (FGF1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice. Cytokine (1997) 0.79

Multi-objective optimization in radiotherapy: applications to stereotactic radiosurgery and prostate brachytherapy. Artif Intell Med (2000) 0.79

Depletion of T lymphocytes with immunotoxin retards the progress of experimental allergic encephalomyelitis in rhesus monkeys. Cell Immunol (1997) 0.77

Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes. Blood Cells Mol Dis (2001) 0.77

Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys (1994) 0.77

Towards noninvasive human tumor physiologic measurements. Int J Radiat Oncol Biol Phys (1995) 0.77

Effect of intraperitoneal ATP on tumor growth and bone marrow radiation tolerance. Acta Oncol (1995) 0.76

1H-NMR measurement of fractional dissociation of imidazole in intact animals. Am J Physiol (1994) 0.76

Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol (1996) 0.76

Dosimetric results from a feasibility study of a novel radiosurgical source for irradiation of intracranial metastases. Int J Radiat Oncol Biol Phys (1996) 0.76

Response of tumour red blood cell flux to hyperthermia and/or hyperglycaemia. Int J Hyperthermia (1989) 0.76

Blood flow and oxygenation status of head and neck carcinomas. Adv Exp Med Biol (1997) 0.76

Size dependent changes in tumor phosphate metabolism after radiation therapy as detected by 31P NMR spectroscopy. Int J Radiat Oncol Biol Phys (1987) 0.75

Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. Int J Radiat Oncol Biol Phys (2001) 0.75

Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: prediction of tumor response to radiation. Int J Radiat Oncol Biol Phys (1991) 0.75

Characterization of the effects of antiangiogenic agents on tumor pathophysiology. Am J Clin Oncol (2001) 0.75

Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease. Radiat Oncol Investig (1998) 0.75

External beam irradiation for inhibition of intimal hyperplasia following prosthetic bypass: preliminary results. Ann Vasc Surg (2001) 0.75

Irradiation for intimal hyperplasia: implications for peripheral arterial bypass. J Am Coll Surg (2000) 0.75

Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee. Int J Radiat Oncol Biol Phys (2001) 0.75

Dosimetric considerations in treating mediastinal disease with mantle fields: characterization of the dose under mantle blocks. Int J Radiat Oncol Biol Phys (1995) 0.75

Comparability of the external vs internal location of radiation in inhibiting neointimal hyperplasia. Cardiovasc Radiat Med (2001) 0.75

Radiation Therapy Oncology Group. Research Plan 2002-2006. Tumor Utilization Committee. Int J Radiat Oncol Biol Phys (2001) 0.75

Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors. J Natl Cancer Inst (1996) 0.75

Effects of hypothermia on rat brain pHi and phosphate metabolite regulation by 31P-NMR. J Appl Physiol (1985) (1989) 0.75

In vivo Optical Spectroscopy of Acoustically Induced Blood Stasis. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75

Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study. Laryngoscope (1998) 0.75

Tumor Detection in vivo with Optical Spectroscopy. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75

Fractionation sensitivity and immunological status in radiation treated murine sarcomas. Int J Radiat Oncol Biol Phys (1990) 0.75

Hyperbaric oxygen and basic fibroblast growth factor promote growth of irradiated bone. Int J Radiat Oncol Biol Phys (1998) 0.75

The effect of hyperglycemia on the tumor response to irradiation given alone or in combination with hyperthermia. Radiat Res (1987) 0.75

The role of oxygen tension distribution on the radiation response of human breast carcinoma. Adv Exp Med Biol (1994) 0.75

Radiation inhibition of arterial restenosis -- a new frontier. Acta Oncol (1999) 0.75

Do changes in tumor blood flow necessarily lead to changes in tissue oxygenation and in bioenergetic status? Adv Exp Med Biol (1994) 0.75

Head and neck compensation for total body irradiation using opposed laterals. Med Dosim (1998) 0.75

Oxygenation and bioenergetic status of murine fibrosarcomas. Adv Exp Med Biol (1992) 0.75

MRI efficacy and effectiveness research: who needs it and who pays for it? J Magn Reson Imaging (1996) 0.75

Predictive value of histologic tumor necrosis after radiation. Int J Cancer (2001) 0.75